Clinical trials for Rheumatoid arthritis investigate a range of treatment strategies and patient populations.

11 total trials for this combination

Showing top 10 of 11 trials

Trials

NCT ID	Title	Status	Phase
NCT02833350	Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)	COMPLETED	PHASE2
NCT01163916	Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical Care	COMPLETED	—
NCT00576433	A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor.	COMPLETED	PHASE4
NCT06475508	Comparison of Complarate® (Tocilizumab Biosimilar) and Actemra® in Patients With Rheumatoid Arthritis	COMPLETED	PHASE3
NCT04512001	MSB11456 in Participants With Moderately to Severely Active Rheumatoid Arthritis	COMPLETED	PHASE3
NCT02983227	A Study to Evaluate the Long-Term Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Rheumatoid Arthritis Enrolled in Study GA29350	COMPLETED	PHASE2
NCT02762838	Comparative Clinical Trial of Efficacy and Safety of BCD-055 and Remicade® in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis	COMPLETED	PHASE3
NCT01759030	Study of Safety and Efficacy of BCD-020 Comparing to MabThera in Patients With Rheumatoid Arthritis	COMPLETED	PHASE3
NCT02889796	Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate	COMPLETED	PHASE3
NCT03025308	Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis	COMPLETED	PHASE3

Related Pages

All Rheumatoid arthritis trials All trials in Chelyabinsk, Russia